Impact of combined treatment with nimesulide and cisplatin on oral carcinoma cells
Authors Barac A, Mitulovic G, Hallström S, Zehetmayer S, Grasl MC, Erovic BM
Received 26 December 2016
Accepted for publication 26 April 2017
Published 19 July 2017 Volume 2017:10 Pages 3607—3616
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Akshita Wason
Peer reviewer comments 2
Editor who approved publication: Dr William Cho
Aleksandra Barac,1 Goran Mitulovic,2 Seth Hallström,3 Sonja Zehetmayer,4 Matthaeus Ch Grasl,5 Boban M Erovic5
1Clinic for Infectious and Tropical Diseases, Clinical Center of Serbia, Belgrade, Serbia; 2Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, Vienna, Austria; 3Institute of Physiological Chemistry, Center for Physiological Medicine, Medical University of Graz, Graz, Austria; 4Medical Statistics, Medical University of Vienna, Vienna, 5Department of Otorhinolaryngology, Head and Neck Surgery, Medical University of Vienna, Vienna, Austria
Background: Despite significant advances in diagnosis and therapy, the rate of survival of patients with oral cancers still remains poor as an appropriate treatment has not been found yet, due to side effects of chemo/radiotherapy.
Aim: This study aimed to identify molecular mechanisms of cell death of oral cancer cells caused by treatment with a nonselective Cox-2 inhibitor in combination with a low-dose chemotherapeutic drug.
Methods: Squamous cell carcinoma (SCC) cells SCC9 and SCC25 were subjected to mono- and combination therapy with nimesulide and cisplatin. Fluorescence-activated cell sorting (FACS), immunohistochemistry, high-pressure liquid chromatography (HPLC), microarray gene chips, and isobaric tags for a relative and absolute quantitation (iTRAQ) system were used.
Results: Increased numbers of apoptotic and necrotic SCC9/SCC25 cells were detected after combined exposure. ATP levels and the energy charge of SCC9 cells were significantly decreased after both individual and combined treatment. We detected and quantified a responsible gene, keratin 6a, and 540 relevant proteins. In SCC25 cells, ATP levels significantly decreased only after combination therapy. After combined treatment of SCC9 cells, significant upregulation of Histon-H2A/H2B/H4 was found, with a local discovery false rate of 0.003 for Histon-H2A and 0.0027 for Histon-H2B, respectively.
Conclusion: Compared to the single-drug treatment, combined treatment of the oral cancer cells with nimesulide and cisplatin increases and induces necrosis and apoptosis through different pathways. A significant effect of the cytoplasmic increase was also observed in histones of cell lines SCC9 and SCC25 that were previously treated with combined nimesulide and cisplatin therapy.
Keywords: apoptosis, nimesulide, cisplatin, gene microarrays, combined therapy
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]